DNM1 Disorder Often Shows Similar Symptoms And Repeat Variants

What was studied

Researchers compiled clinical and genetic information from 95 people with DNM1-related disorder, a rare developmental and epileptic encephalopathy. They gathered cases from multiple sources and organized the symptoms using the Human Phenotype Ontology framework.

The goal was to better describe the genotypic and phenotypic landscape of DNM1-related disorder, including whether certain variants are associated with certain symptoms. The researchers also compared the overall pattern of symptoms in DNM1-related disorder with several other genetic epilepsy conditions: SCN2A, SCN8A, STXBP1, and SYNGAP1.

What they found

The study found that disease-causing DNM1 variants cluster in specific mutational hotspots in the gene, with hotspots reaching 'Strong' and 'Moderate' evidence for pathogenicity based on ACMG guidelines. Overall, people with DNM1-related disorder had a relatively homogeneous pattern of symptoms compared with SCN2A-, SCN8A-, STXBP1-, and SYNGAP1-related conditions.

Two recurrent variants were associated with particular clinical features. The p.R237W variant was associated with bilateral tonic-clonic seizures, infantile spasms, and dystonia. The p.I398_R399insCR variant was associated with severe hypotonia, profound global delay, and cortical visual impairment. The study also described five people with homozygous loss-of-function variants; they were clinically similar to dominant-negative DNM1-related disorder, but microcephaly and brain MRI abnormalities were more common in this group.

Limits of the evidence

This was mainly a descriptive study, so it cannot show that a specific variant determines a specific symptom in every person. Even though this was the largest DNM1 cohort reported so far, 95 people is still a limited sample for drawing firm conclusions, especially for individual variants and the subgroup with homozygous loss-of-function variants, which included only five people.

The data came from multiple sources, so the amount and quality of clinical detail may not have been the same for every person. The abstract does not provide details about treatment response, long-term outcomes, or how symptoms may change over time.

For families and caregivers

For families, this study suggests that DNM1-related disorder may have a relatively consistent pattern of symptoms compared with some other genetic epilepsy conditions, and that certain recurrent gene changes may be associated with certain clinical features. This may help doctors recognize the condition and support discussions about possible symptoms.

The paper also states that DNM1 is an attractive target for targeted therapy development, but this study did not test any treatment. So, while the findings improve understanding of the disorder, they do not yet show that care or outcomes will change right away.

What to watch next

Useful next steps would include larger, carefully followed cohorts and studies that examine whether variant-specific findings are reproducible and clinically useful for counseling or future therapy development.

Terms in this summary

developmental and epileptic encephalopathy

A group of conditions with epilepsy and developmental problems that can affect learning, movement, and behavior.

variant

A change in a gene's DNA sequence.

pathogenicity

How likely a gene change is to cause disease.

genotype-phenotype correlation

A relationship between a specific genetic change and a pattern of symptoms.

dominant-negative

A disease mechanism where an altered gene product interferes with the normal one.

loss-of-function

A gene change that reduces or removes the gene's usual activity.

hypotonia

Low muscle tone, sometimes called "floppiness."

cortical visual impairment

Vision problems caused by the brain having trouble processing visual information, rather than a problem in the eyes themselves.